ELOCP27

Across TCGA pan-cancer cohorts, ELOCP27 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated ELOCP27 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher ELOCP27 RNA is associated with better overall survival. In most high-consensus cancer types, elevated ELOCP27 expression acts as an unfavorable survival marker, although some lineages such as OV and LGG show a favorable association.

OV, LGG, and COAD are the cancer types where ELOCP27 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	IV	0.609	0.246	<.001	36	view →
LGG	OS	Median	All	0.935	0.852	<.001	26	view →
COAD	DFS	Tertile	IV	0.277	0.585	.003	24	view →
HNSC	OS	Quartile	III,IV	0.803	0.617	.019	15	view →
KIRP	DFS	Tertile	All	0.301	0.638	.003	12	view →
PAAD	OS	Tertile	II,III,IV	0.376	0.581	.031	9	view →
SKCM	DFS	Quartile	III,IV	0.140	0.341	.043	3	view →
DLBC	DFS	Median	IV	1.000	0.510	.030	3	view →
KIRC	DFS	Tertile	II,III,IV	0.381	0.570	.047	3	view →
ESCA	DFS	Median	All	0.459	0.594	.025	3	view →
READ	OS	Median	II,III,IV	0.334	0.807	.037	2	view →
LAML	DFS	Quartile	All	0.672	0.492	.045	2	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

ELOCP27–OV (OS)

Open the OV breakdown →